This seasoned executive with 30 years’ leadership experience in Biostatistics, Epidemiology and Data Sciences including Artificial Intelligence/Machine Learning, including recent experience with the Food and Drug Administration leading special data analytics projects with the Chief Data Officer takes on a new role with industry.
Aloka Chakravarty is now identified as VP, Head of Enterprise RWE (I&I, IM), Pfizer. She most recently served as Director, Data Analytics and Senior Statistical Advisor, Office of the Commissioner within the Food and Drug Administration. Recent experience includes leading RWD/RWE initiative at OC on the design, analysis and interpretation of RWD and RWE COVID-19 research projects with national partners including CMS, NIH, VA, CDC and international regulatory agencies (EMA, Health Canada & ICMRA).
